2 results
Approved WMOCompleted
To demonstrate the bioequivalence of sorafenib with probenecid relative to sorafenib without probenecid based on the AUC in patients with unresectable hepatocellular cancer, advanced clear-cell renal cell carcinoma, locally recurrent or metastatic,…
Approved WMORecruiting
To establish that recovery time from a bronchoprofocation test is faster with HFNC compared to no interfention